Four incubator projects approved

The Office of the Chief Scientist has approved four new incubator projects in the life sciences field at an investment of NIS 9 million, the Ministry of Industry, Trade and Labor said Sunday.

By AVI KRAWITZ
September 14, 2006 06:45

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For a symbolic $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Don't show it again

The Office of the Chief Scientist has approved four new incubator projects in the life sciences field at an investment of NIS 9 million, the Ministry of Industry, Trade and Labor said Sunday. Three of the approved companies are active in the biotechnology sector, while the remaining one is in medical devices. In addition, the committee approved NIS 2m. for the second year project at the Bioline incubator in Jerusalem.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS